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by using Bio-FM system in comparison with the Lowenstein Jensen medium.
Patients and methods: A total of 50 smear AFB positive sputum samples were included in this
study and received from three groups. Group I: Thirty four patients with fresh sputum smear
+ve (new cases). Group II: Ten relapsed cases. Group III: Six treatment failure cases. All cases
were exposed for thorough history taking, complete physical examination, routine laboratory tests
including ESR, plain chest X-ray-PA and lateral view if needed, sputum smear for acid fast bacilli
(Zeil Neelsen staining), tuberculin skin test using Mantoux technique, sputum culturing on Lowen-
stein Jensen medium and Bio-FM medium.
Results: The shortest mean detection times on the two studied isolation media were for the cases
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250 S.A. Essa et al.Bio-FM it was 10 ± 5.752 days. While the longest times were for the cases of minimal lesion, on
Lowenstein Jensen, it was 24 days (±11.449) and on Bio-FM it was 15 days (±10.905). The mean
detection times of moderately advanced cases on Lowenstein Jensen, it was 19.57 days (±9.086)
and on Bio-FM was 12.65 days (±8.074).
Conclusion: Bio-FM showed greater superiority in detection time over Lowenstein Jensen with
no signiﬁcant difference between the two media in detection rate.
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Tuberculosis (T.B.) still represents a monumental problem in
the world, with almost 9.4 (range 8.9–9.9) million new cases
in 2008 (139 per 100,000 population) compared with 9.27 mil-
lion new cases (139 per 100,000 population) in 2007 and 9.24
million new cases (140 per 100,000 population) in 2006 ([29]).
Although smear microscopy shows the highest rates of dis-
ease detection yearly worldwide [15], culture systems are used
for isolation of tuberculous bacilli as they are more sensitive
than smear microscopy. Lowenstein Jensen culture (LJ) is the
most widely used in low-income countries, it is an egg based
medium developed from Jensen’s modiﬁcation of Lowenstein’s
formula. The inoculation time of the bacilli is up to 8 weeks [1].
LJ medium is commonly used in clinical laboratories to iso-
late acid fast organisms from sterile and non sterile sources.
Bacterial growth on cultures is considered as positive as soon
as colonies appear on LJ medium and it is conﬁrmed by Ziehl
Neelsen (ZN) staining. In practice, 40–70% of patients with
tuberculosis isolated in culture have positive smears [18].
Bio-FM is an enriched Middlebrook 7H9 medium, opti-
mized for rapid mycobacterial growth whose selectivity is en-
hanced by a selective VCA (Vancomycin, Colistin and
Amphotericin B) supplement, containing a colored indicator
that allows the detection of positive cultures which turn into
a dark blue to violet color. The aspect of the culture should
also permit species identiﬁcation (Mycobacterium tuberculosis
or atypical mycobacteria). The results are conﬁrmed by
microscopy after ZN staining, then by re-inoculation on LJ
medium and by identiﬁcation by biochemical tests [20].
Aim of the work
To evaluate the detection rate and time of Mycobacterium
tuberculosis by using the Bio-FM system in comparison with
the Lowenstein Jensen medium.
Patients and methods
The study was conducted on sputum. A Total 50 of AFB smear
positive sputum samples were received from three groups:
– Group I: 34 patients with fresh sputum smear positive (New
cases).
– Group II: 10 Relapsed cases.
– Group III: 6 Treatment failure cases.
All cases were exposed for: Thorough history taking, com-
plete physical examination, routine laboratory tests including
ESR, Plain chest X-ray-PA and lateral view if needed, sputumsmear for acid fast bacilli (Ziehl–Neelsen staining). Sputum col-
lection was done in the early morning, patients were instructed
to expectorate a deep respiratory specimen with no nasal secre-
tions or saliva. Ideally, the sputum was obtained on 3 consecu-
tive days. 5–10 ml of sample each time was appropriate. For
patients who were unable to produce sputum, hypertonic saline
(5–15%) was nebulized for induction [19]. Tuberculin skin test
was applied using Mantoux technique, by intra-dermal injec-
tion of 0.1 ml of PPD tuberculin (5 TU) into the skin of the vo-
lar aspect of the forearm and the results were detected after 48–
72 h. Test signiﬁcance depends on the presence or absence of
indurations which was expressed in millimeters. Sputum cultur-
ing was done on two slopes of Lowenstein Jensen medium per
specimen, with 0.25–0.5 mL of each specimen and incubated
at 37 C for 8 weeks. The LJ slants were inspected weekly.
Growth on the LJ slants resembling mycobacterial colonies
(i.e., rough, tough and buff-colored) was subjected to ZN stain-
ing to conﬁrm the presence of AFB [28]. Sputum culturing was
done on Bio-FM medium which was formed of (ammonium
sulfate (NH4SO4), magnesium sulfate, monopotassium phos-
phate (KH2PO4), zinc sulfate (ZnSO4), disodium hydrogen
phosphate (Na2HPO4), copper (II) sulfate (CuSO4), calcium
chloride (CaCl2), sodium chloride (NaCl), ammoniacal iron cit-
rate, sodium citrate, pyridoxine (Vit.B6), biotin (Vit.B7), amino
acids, fatty acid, pancreatic digest of casein, bovine albumin,
glycerol, glucose, distilled water, catalase and growth indicator.
Bio-FM V.C.A. supplement is formed of Vancomycin, Colistin
and Amphotericin B. Samples were incubated for 5–6 weeks at
37 C. Reading cycle was performed by the following way: 2–4
weekly readings for 3–4 weeks, then twice a week for another
2 weeks.
Reading of Bio-FM medium generally was in 2 phases:
(1) 1st phase: examination of the sediment and liquid med-
ium without shaking the tube– The bottom of the tubes and the liquid medium were
carefully examined:
– If no signs of growth were present (no cloudiness,
turbidity, dark blue/violet grains or ﬂakes): the 2nd
phase of reading was done.
– If signs of growth were present:
– Dark blue/violet grains or small ﬂakes that have set-
tled at the bottom of the tube: presumption of MTB.
– Cloudiness or turbidity, with a color ranging from
dark blue to violet, and tending to partially settle at
the bottom of the tube: suspicion of atypical myco-
bacteria. This possibly was conﬁrmed by the 2nd p-
hase of reading.(2) 2nd phase: examination of the sediment after shaking
the tube
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Lowenstein Jensen and bio-fm media in identiﬁcation of Mycobacterial TB 251– The tube was placed at eye level (preferably examined
in daylight) and the sedimentation pellet situated in
the bottom of the tube was re-suspended by a gentle
to-and-fro movement of the tube:
– If no signs of growth (no cloudiness, turbidity, dark
blue/violet grains or ﬂakes): negative culture, incu-
bation of the medium continued.
– If signs of growth were present:
– Dark blue/violet grains or small ﬂakes: presumption
of MTB.
– Cloudiness or turbidity, with color dark blue/violet
color: suspicion of atypical mycobacteria.
– The presence of a homogeneous cloudiness (possibly
with very slight blue color of the medium), observed
after 3 days of incubation, was suggestive of
contamination.
– The dark blue color, indicative of growth of myco-
bacteria, was visible even in the presence of cellular
debris or insoluble particles.
– Counting and a morphological study of colonies were
done between the 2nd and the 8th week after inocu-
lation (as recommended).e 1 Comparison between Lowenstein Jensen and Bio-FM as re
rding to radiological extent of T.B lesions.
n Media No.
mal Lowenstein Jensen 14
Bio-FM 14
erately advanced Lowenstein Jensen 21
Bio-FM 20
dvanced Lowenstein Jensen 12
Bio-FM 12
e 2 Comparison between Lowenstein Jensen and Bio-FM as re
rding to presence or absence of cavitary lesion.
ia Lesion No. R
enstein Jensen Cavitary 13 12
Non-cavitary 34 11
M Cavitary 13 5–
Non-cavitary 33 5–
e 3 Comparison between Lowenstein Jensen and Bio-FM as reg
ration ranges in days.
tion range Positive cases on L.J
No. %
ays 0 0
14 days 15 31.91
–21 days 19 40.43
–28 days 5 10.64
–35 days 3 6.38
–42 days 3 6.38
–49 days 1 2.13
–56 days 1 2.13
l 47 100Identiﬁcation
When bacterial growth was detected in Bio-FM medium, the
colored particles were taken with a Pasteur pipette and pres-
ence of AFB was looked for. The presence of mycobacteria
in the medium was conﬁrmed by AFB microscopy after ZN
staining, then by re-inoculation of bacteria onto LJ medium
and identiﬁcation by biochemical tests. The results were tabu-
lated and statistically analyzed.
Results
Tables 1–5 This study included 50 sputum smear positive
tuberculous patients, who were classiﬁed into 34 cases (group
I) representing 68% of the total cases, 10 relapsed cases (group
II) and 6 treatment failure cases (group III) representing 20%
and 12% of the total cases respectively. The results showed the
age distribution among the studied groups and it was noticed
that the range of age in group I was from 19 to 67 years with
the mean age 39.47 ± 15.122 years and in group II it was from
22 to 63 years with the mean age 41.60 ± 11.983 years, whilegards mean detection times and duration ranges in days classiﬁed
Range Mean ± SD t p
16–53 24.00 ± 11.449 13.408 <0.001
9–43 15.00 ± 10.905
12–40 19.57 ± 9.086 2.574 <0.05
5–34 12.65 ± 8.074
11–31 17.50 ± 6.802 14.166 <0.001
5–19 10.00 ± 5.752
gards mean detection times and duration ranges in days classiﬁed
ange Mean ± SD t p
–20 14.39 ± 1.938 4.491 <0.001
–52 22.65 ± 10.259
14 7.62 ± 2.219 3.366 <0.001
43 14.36 ± 9.384
ards number and percentage of positive cases classiﬁed according
Positive cases on Bio-FM
No. %
14 30.43
20 43.48
7 15.23
2 4.35
1 2.17
1 2.17
1 2.17
0 0
46 100
Table 4 Comparison between Lowenstein Jensen and Bio-FM as regards number and percentage of positive and negative cases
among the studied groups.
Patient group No. Media Positive Negative
No. % No. %
Group I (new cases) 34 Lowenstein Jensen 34 100 0 0
Bio-FM 33 97.1 1 2.9
Group II (relapse) 10 Lowenstein Jensen 8 80 2 20
Bio-FM 8 80 2 20
Group III (treatment failure) 6 Lowenstein Jensen 5 83.33 1 16.67
Bio-FM 5 83.33 1 16.67
Total 50 Lowenstein Jensen 47 92 3 6
Bio-FM 46 94 4 8
Table 5 Comparison between Lowenstein Jensen and Bio-FM as regards mean detection times in days.
Media No. Range Mean ± SD t p
Lowenstein Jensen 45 11–52 20.62 ± 9.640 23.816 <0.001
Bio-FM 45 5–43 12.58 ± 8.622
252 S.A. Essa et al.in group III it was from 19 to 54 years with the mean age
37.50 ± 12.518 years.
The results showed also the sex distribution among the
studied groups, 39 males were included in this study distrib-
uted as 26 in group I, 8 in group II and 5 in group III, 11 fe-
males were included in this study distributed as 8 in group I, 2
in group II and only one female was in group III.
Discussion
Figs. 1 and 2 Although considerable efforts have been made to
improve the sensitivity of sputum smear microscopy in the diag-
nosis of pulmonary tuberculosis, it still lacks sensitivity, espe-
cially in children and HIV positive people [24], so culturing of
MTB has become increasingly important in the last decades.Figure 1 Comparison between positive and negative results on
Lowenstein Jensen. Yellow colonies ofMycobacterium tuberculosis
representing positive growth are clearly seen in (A) which are
absent in (B).
Figure 2 Comparison between positive and negative results on
Bio-FM. Cloudiness and turbidity with dark violet dots demon-
strating positive growth are clearly seen in (A). Clear aspect with
no turbidity, cloudiness or dark violet dots is seen in (B) reﬂecting
negative results.Culture is used to detect cases with low mycobacterial loads
and is also requested in cases at risk of drug-resistant TB for
drug susceptibility testing or in cases where disease due to an-
other member of the mycobacterium genus is suspected.
Different culture media are in use for the isolation of myco-
bacteria. The most common are based on egg and also contain
high concentrations of malachite green to overcome contami-
nation with other bacteria. In general, only solid Lowenstein
Jensen medium is available in many low-income countries, as
it is made on site. However, culture on Lowenstein Jensen is
long (3 weeks to 3 months for MTB) and time consuming.
The Bio-FM broth is an enriched Middlebrook medium that
has been in the market for several years, but it has never been
evaluated in low-income countries. The only study published
on the evaluation of this medium in a high TB incidence coun-
try was made by Ramarokoto et al. [20].
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patients, who were classiﬁed into 34 new cases (group I) repre-
senting 68% of the total cases, 10 relapsed cases (group II) and
6 treatment failure cases (group III) representing 20% and
12% of the total cases respectively.
The shortest mean detection times on the two studied isola-
tion media were for the cases with far advanced lesion on chest
X-ray. On Lowenstein Jensen, it was 17.50 ± 6.802 days, and
on Bio-FM it was 10 ± 5.752 days. The longest times were for
the cases of minimal lesion. On Lowenstein Jensen, it was
24 ± 11.449 days, and on Bio-FM it was 15 ± 10.905 days.
The mean detection times of moderately advanced cases on
Lowenstein Jensen was 19.57 ± 9.086 days, and on Bio-FM
was 12.65 ± 8.074 days.
The mean detection time on Bio-FM was signiﬁcantly
shorter than that on Lowenstein Jensen in cases of moderately
advanced tuberculous lesions on chest X-ray (P-value < 0.05),
while in cases with minimal and far advanced radiological le-
sion, it was highly signiﬁcant (P-value < 0.001).
In this study, patients represented by cavitary lesion on
chest X-ray formed 26% of the total cases reviewed in this
study (13 cases of total 50 cases). A previous study made by
Leung et al. [10] showed that the incidence of cavitary lesion
ranged between 13–24%. Go´mez et al. [8] showed incidence
about 19% and 34% in 2 studied groups.
It was also noted from that the mean detection times on both
media in cases with cavitary lesion on chest X-ray were highly sig-
niﬁcantly shorter than the cases without cavitary
lesions (P-value < 0.001). The mean detection time on
Lowenstein Jensen for cases with cavitary lesions was
14.39 ± 1.938 days, compared with that for cases with non cavi-
tary lesion which was 22.65 ± 10.259 days, and on Bio-FMmean
detection timewas 7.62 ± 2.219 days for caseswith cavitary lesion
and 14.36 ± 9.384 days for cases with non cavitary lesion.
Palaci et al. [14] demonstrated the relationship between
quantitative sputum bacillary load and the radiological extent
of tuberculous lesions as well as presence or absence of cavi-
tary lesion in chest X-ray. In their study there was a positive
correlation between radiological extent of pulmonary tubercu-
lous lesions and the sputum bacterial loads (more advanced le-
sions associated with more sputum bacterial loads), also they
demonstrated that tuberculous cavitary lesions were associated
with more sputum bacterial loads.
Cavitary disease also has been shown to be an important
risk factor for treatment failure and relapse and possibly for
development of drug resistance during treatment [3].
According to Rathman et al. [21] and Matsuoka et al. [12],
higher bacterial loads were found in sputum samples associ-
ated with a shorter detection time. Another study made by Per-
rin et al. [16], investigated the relationship between detection
time of MTB and presence or absence of cavitary disease by
using the BacT/ALERT culture system. The mean detection
time was signiﬁcantly lower in patients with cavities (8.4 days)
than in those without cavitation (16.2 days). In patients with
four to ﬁve cavities, the mean detection time was lower
(5.3 days) than those with one to three cavities (13.4 days)
and without cavities (17.5 days). A similar study was made
by Palaci et al. [14], in which BACTEC 460 system was used
for culture of MTB instead of BacT/ALERT system. In the
later study, shorter mean detection time (3.5 days) was associ-
ated with cavitary disease and longer mean detection time
(9.0 days) was associated with non cavitary disease. Thesedetection time values were lower than those reported by Perrin
et al. [16] suggesting that growth in the BACTEC 460 is more
rapid than in the BacT/ALERT and/or the overall mycobacte-
rial loads of their patients were much higher.
The study clearly follows these conclusions; we reported
relationship between detection time of MTB and radiological
extent of tuberculous lesion as well as the presence or absence
of cavitary disease but by culturing on Lowenstein Jensen and
Bio-FM media in comparative manner.
From above results, we can also conclude that the detection
time values on Bio-FM are lower than those on Lowenstein
Jensen either in cases with or without cavitary lesion and what-
ever the radiological extent of the tuberculous lesions is.
Diabetic patients represented 14% of the total cases in this
study (7 cases of total 50 cases), similar to those rates reported
by Yamagishi et al. [30] which was 14.1% but slightly more than
those reported by Yamagishi et al. [31] and much more than that
reported by Aktogu et al. [2] which was 7.8%. The incidence was
only 1% in the study made by Lienhardt et al. [11], in which only
9 cases were diabetic among 647 pulmonary tuberculous cases.
All 7 tuberculous patients having DM gave positive growth
onBio-FMcomparedwith only 6 patients onLowenstein Jensen.
These patients also showed signiﬁcant shorter mean detection
time (P-value < 0.05) on Bio-FM (12 ± 5.292 days) compared
with that of on Lowenstein Jensen (20.67 ± 6.947 days).
In this study, diabetic patients had shorter mean detection
times on either Lowenstein Jensen or Bio-FM than those of
non diabetic patients. This may be contributed to higher bacil-
lary burden at presentation of tuberculosis in diabetic patients
[5] or to the prevalence of cavitary disease in diabetics which
was supported by Umut et al. [26] and Ekim et al. [6], and
so higher bacterial loads found in their sputum were associated
with shorter detection times [21,12].
Five patients under anticancer chemotherapy having tuber-
culosis were present in this study, representing 10% of the total
studied groups. The mean detection time of these patients was
shorter than that of patients who have nothing besides
pulmonary tuberculosis, on either Lowenstein Jensen
(21.2 ± 4.382 days versus 23.63 ± 12.937 days) or Bio-FM
(11.4 ± 0.548 days versus 16.29 ± 12.221 days). These Patients
also showed signiﬁcant shorter mean detection time (P-va-
lue < 0.05) on Bio-FM (11.4 ± 0.548 days) compared with
that on Lowenstein Jensen (21.2 ± 4.382 days). Drug users
having pulmonary tuberculosis had shorter mean detection time
than non-drug users, on either Lowenstein Jensen
(17.6 ± 5.983 days versus 23.63 ± 12.937 days) or Bio-FM
(10.4 ± 5.225 days versus 16.29 ± 12.221 days). These
patients also showed highly signiﬁcant shorter mean detection
time (P-value < 0.001) on Bio-FM (10.4 ± 5.225 days)
compared with that on Lowenstein Jensen (17.6 ± 5.983 days).
Patients having chronic obstructive pulmonary disease repre-
sented 8% of the total cases reviewed in this study (4 cases of
total 50 cases), more than the percentage present in the study
made by Leung et al. [10] which was 5.8%. Patients having
COPD besides pulmonary tuberculosis have a shorter mean
detection time than those who have nothing besides pulmonary
tuberculosis, on either Lowenstein Jensen (18.75 ± 6.292 days
versus 23.63 ± 12.937 days) or Bio-FM (11 ± 6.272 days ver-
sus 16.29 ± 12.221 days). These Patients also showed signiﬁ-
cant shorter mean detection time (P-value < 0.005) on Bio-
FM (11 ± 6.272 days) compared with that on Lowenstein Jen-
sen (18.75 ± 6.292 days).
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pulmonary tuberculosis cases reviewed in this study was 8%
(4 cases of total 50 cases). It was noted that tuberculous patients
with CRF have a shorter mean detection time than those who
have nothing besides pulmonary tuberculosis, on either Lowen-
stein Jensen (15 ± 2.449 days versus 23.63 ± 12.937 days) or
Bio-FM (7.5 ± 2.082 days versus 16.29 ± 12.221 days). These
Patients also show signiﬁcant shorter mean detection time (P-
value < 0.001) on Bio-FM (7.5 ± 2.082 days) compared with
those on Lowenstein Jensen (15 ± 2.449 days). Patients with
chronic renal failure and/or renal transplants are known to be
a high-risk group for tuberculosis. The risk of developing tuber-
culosis in these patients is about 6.9–52.5-fold compared to risk
in the general population [13].
In this study, patients on corticosteroid therapy represented
8% of the total cases reviewed in this study (4 cases of total 50
cases), more than the percentage present in two studies made by
Kobashi andMatsushima [9] which was 2.1% in the studymade
between 1991 and 1996 and 4.3% in the study made between
1996 and 2001. In a more recent multi-location study made by
Falagas et al. [7] the percentage ranged from 0% to 13.8%. In
this study, tuberculous patients under corticosteroid therapy
had the shortest mean detection time among the studied groups
who either having another underlying disease or receiving other
medical treatment besides having pulmonary tuberculosis, on
either Lowenstein Jensen (13.75 ± 1.258 days) or Bio-FM
(7.25 ± 1.708 days). These Patients also showed a highly signif-
icant shorter mean detection time (P-value < 0.001) on Bio-
FM (7.25 ± 1.708 days) compared with that on Lowenstein
Jensen (13.75 ± 1.258 days). It is widely accepted that cortico-
steroid therapy may reactivate a latent TB infection or increase
the risk of new infection by suppressing cell-mediated immune
responses thus causing a reduction in resistance to infections.
It is also known that large doses of corticosteroids suppress
antibody formation. Several studies have shown an emer-
gence/reactivation of TB in patients treated with systemic corti-
costeroids; the percentage varies from 0% to 3% [22].
Patientswhohavenothingbesidespulmonarytuberculosishave
statisticallyinsigniﬁcantshortermeandetectiontimeofgrowth(P-
value > 0.05) onBio-FM(16.29 ± 12.221 days) comparedwith
thatonLowensteinJensen(23.63 ± 12.937 days).
In this study, we compare between both media as regards
duration range. No cases gave positive results on Lowenstein
Jensen with duration up to 7 days compared with 14 cases
who gave positive results on Bio-FM representing 30.43% of
the total number of cases. Regarding duration range of 8–
14 days, 15 cases gave positive results on Lowenstein Jensen
representing 31.91% of the total number of cases, compared
with 20 cases on Bio-FM representing 43.48% of the total
cases. The total number of cases that gave positive results on
Bio-FM with duration range up to 14 days was 34 cases repre-
senting 73.91% compared with 15 cases on Lowenstein Jensen
representing only 31.91% of the total number of cases. With
duration range of 14–21 days, 19 cases gave positive results
on Lowenstein Jensen representing 40.43% of the total num-
ber of cases compared with 7 cases on Bio-FM representing
15.23% of the total number of cases. With duration range be-
yond 14 days up to 56 days, only 5 cases gave positive results
on Bio-FM representing 10.86% of the total number of cases
compared with 13 cases on Lowenstein Jensen representing
27.65% of the total number of cases. It was noted that no cases
gave positive results on Bio-FM after 49 days.In this study, there was no signiﬁcant difference between
the two media in detection rate (94% of the total cases gave
positive results on Lowenstein Jensen compared with 92%
on Bio-FM). All cases of group I gave positive results on
Lowenstein Jensen (100%) compared with 33 cases on Bio-
FM (97.1%). Patients of group II and III have the same results
on both media. 8 cases gave positive results in group II and 5
cases in group III. The mean detection time of cases on Bio-
FM was highly signiﬁcantly shorter than that of cases on
Lowenstein Jensen (12.58 ± 8.622 days for Bio-FM versus
20.62 ± 9.640 days for Lowenstein Jensen – P-value < 0.001).
Lowenstein Jensen was incorporated in many studies in
comparison with other media for culturing of MTB. Van Grie-
thuysen et al. [27] compared culturing of respiratory specimens
on Lowenstein Jensen in comparison with Fluorescent BAC-
TEC 9000 MB System and Septi-Chek AFB System. In their
study, 76 smear AFB positive samples were cultured on the
three media, 67 cases only gave positive results on Lowenstein
Jensen with a detection rate of about 88.2% and themean detec-
tion time was 22.5 ± 8.8 days. Two years later, in 1998, 2 stud-
ies were published. The ﬁrst was made by Chew et al. [4] who
cultured 149 sputum samples on Lowenstein Jensen in compar-
ison withMGIT and Bactec systems, only 68 samples were AFB
positive, of which 51 samples gave positive results on Lowen-
stein Jensen with a detection rate of 75% and the mean detec-
tion time was 25 days. The second was made by Tortoli et al.
[25] who cultured 179 respiratory samples on Lowenstein Jen-
sen in comparison with ESPCulture System II (now namedVer-
saTREK) and BACTEC 460 TB. 116 samples gave positive
results on Lowenstein Jensen with a detection rate of 64.8%
and the mean detection time was 28.56 ± 10.8 days.
Somoskovi et al. [23] cultured 55 smearAFBpositive sputum
samples on Lowenstein Jensen in comparison with BACTEC
MGIT 960 System and BACTEC 460 TB System. 45 cases gave
positive results on Lowenstein Jensen with a detection rate of
about 81.8% and the mean detection time was 20.1 days.
Piersimoni et al. [17] cultured 67 cases on Lowenstein Jen-
sen in comparison MB/BacT ALERT 3D System with Radio-
metric BACTEC System. 62 cases gave positive results on
Lowenstein Jensen with a detection rate of about 92.53%
and the mean detection time was 20.6 days.
Only one previous study compared the use of Lowenstein Jen-
sen with Bio-FM. in this study, Ramarokoto et al. [20] found no
signiﬁcant difference in detection rate between Lowenstein Jensen
compared with that on Bio-FM. It was 93.15% and 97.9% for
Lowenstein Jensen and Bio-FM respectively. In accordance with
our study, the mean detection time of cases on Bio-FMwas highly
signiﬁcantly shorter than that of cases on Lowenstein Jensen
(12.42 days versus 20.7 days – P-value < 0.001).Conclusion
Bio-FM showed greater superiority in detection time over
Lowenstein Jensen with no signiﬁcant difference between the
two media in detection rate. This superiority occurs in both
patients groups who had nothing besides tuberculosis and in
patients who had additional morbidity variables (like DM,
COPD) or receiving treatment (such as corticosteroids or
anticancer chemotherapy), so Bio-FM broth may replace
Lowenstein Jensen medium in the future for its better
performance.
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